Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Association of aspirin use and hormone receptor status with breast cancer risk.

Publication ,  Journal Article
Woloshin, S; Schwartz, LM
Published in: JAMA
September 22, 2004

Duke Scholars

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

September 22, 2004

Volume

292

Issue

12

Start / End Page

1426 / 1427

Location

United States

Related Subject Headings

  • Risk
  • Receptors, Progesterone
  • Receptors, Estrogen
  • Humans
  • General & Internal Medicine
  • Breast Neoplasms
  • Aspirin
  • Anticarcinogenic Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Woloshin, S., & Schwartz, L. M. (2004). Association of aspirin use and hormone receptor status with breast cancer risk. JAMA, 292(12), 1426–1427. https://doi.org/10.1001/jama.292.12.1426-b
Woloshin, Steven, and Lisa M. Schwartz. “Association of aspirin use and hormone receptor status with breast cancer risk.JAMA 292, no. 12 (September 22, 2004): 1426–27. https://doi.org/10.1001/jama.292.12.1426-b.
Woloshin S, Schwartz LM. Association of aspirin use and hormone receptor status with breast cancer risk. JAMA. 2004 Sep 22;292(12):1426–7.
Woloshin, Steven, and Lisa M. Schwartz. “Association of aspirin use and hormone receptor status with breast cancer risk.JAMA, vol. 292, no. 12, Sept. 2004, pp. 1426–27. Pubmed, doi:10.1001/jama.292.12.1426-b.
Woloshin S, Schwartz LM. Association of aspirin use and hormone receptor status with breast cancer risk. JAMA. 2004 Sep 22;292(12):1426–1427.
Journal cover image

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

September 22, 2004

Volume

292

Issue

12

Start / End Page

1426 / 1427

Location

United States

Related Subject Headings

  • Risk
  • Receptors, Progesterone
  • Receptors, Estrogen
  • Humans
  • General & Internal Medicine
  • Breast Neoplasms
  • Aspirin
  • Anticarcinogenic Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • 42 Health sciences